Colorectal Cancer Clinical Trials in Austin

Showing 161-180 of 227 trials

Collection of Gastrointestinal Malignant and Non-malignant Human Samples

NCT03415919

To collect human tissue, blood, and fecal samples from patients suffering from Inflammatory Bowel Disease and Colorectal Cancer. The samples will be used to establish biomimetic human organ-on-a-chip technology, as well as study the role of the microbiome in the pathogenesis in human gastrointestinal diseases.

Inflammatory Bowel DiseasesColo-rectal Cancer

University of Texas at Austin300 participantsStarted Jul 2018

Austin, Texas, United States

COMPLETED< 1 mile

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

NCT03821948

The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of colorectal cancer (CRC).

Colorectal Cancer

Exact Sciences Corporation5,131 participantsStarted Jan 2019

Tempe, Arizona, United States • Chula Vista, California, United States • Huntington Beach, California, United States +37 more locations

Collection of Gastrointestinal Malignant and Non-malignant Human Samples

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Colorectal Cancer Trials in Other Cities

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

A Study in Second Line Metastatic Colorectal Cancer

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

Sym004 in Patients With Advanced Solid Tumors

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

The National CT Colonography Trial

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Other Conditions in Austin